Pharma BD Deal Intelligence
Roche buys Constitution Medical Investors for $220 million, acquiring the Bloodhound system that combines a digital morphologic analyser, cell counter and…
Roche framed the acquisition as a $2B+ hematology market entry, citing space-saving Bloodhound automation and integrated lab-solutions positioning; commentary…
Industry trade analysis noted the Bloodhound platform could accelerate Roche's hematology market entry by leapfrogging legacy impedance/flow-cytometry…
Source summaries from our enrichment pipeline; follow links for originals.
All 8 sources with sentiment breakdown →
Roche Diagnostics acquired Constitution Medical for $220M cash plus development-related contingent payments; CMI Bloodhound platform served as Roche's hematology diagnostics center of excellence.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Roche Holding AG / Constitution Medical Investors Inc. (this deal) | 2013 | $220M | 56 |
| Roche Holding AG / Chugai Pharmaceutical Co. Ltd. | 2002 | $1.4B | 100 |
| Roche Holding AG / Ventana Medical Systems Inc. | 2008 | $3.4B | 88 |
| Roche Holding AG / Corange Ltd. (Boehringer Mannheim Group) | 1997 | $11.0B | 88 |
| Roche Holding AG / Ventana Medical Systems Inc. | 2007 | $3.4B | 88 |
| Roche Holding AG / Foundation Medicine, Inc. | 2015 | $1.1B | 87 |
| Roche Holding AG / Foundation Medicine, Inc. | 2018 | $5.3B | 85 |
← Browse all deals · How we score deals
More: 2013 deals · Roche Holding AG deals · Hematology deals